NASDAQ : NXTC
NextCure, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 11.63M | 12.69M | 15.72M | 19.71M | 21.71M | 20.57M |
| Research & Development | 27.20M | 44.92M | 41.49M | 47.93M | 54.20M | 50.19M |
| Operating Expenses | 38.82M | 57.62M | 57.21M | 67.64M | 75.91M | 70.77M |
| Operating Income | -38.82M | -57.62M | -57.21M | -67.64M | -75.91M | -70.77M |
| Interest Expense | -77.00K | |||||
| Interest & Investment Income | 1.15M | 1.77M | 4.09M | 4.91M | 1.17M | 1.40M |
| EBT Excluding Unusual Items | -37.67M | -55.84M | -53.11M | -62.72M | -74.74M | -69.45M |
| Merger & Restructuring Charges | -756.00K | |||||
| Gain (Loss) on Sale of Investments | 9.00K | 57.00K | ||||
| Asset Writedown | -5.08M | -1.79M | ||||
| Pretax Income | -42.75M | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M |
| Net Income | -42.75M | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M |
| Net Income to Common | -42.75M | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M |
| Shares Outstanding (Basic) | 4.30M | 2.84M | 2.33M | 2.32M | 2.31M | 2.30M |
| Shares Outstanding (Diluted) | 4.30M | 2.84M | 2.33M | 2.32M | 2.31M | 2.30M |
| EPS (Basic) | -9.94 | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 |
| EPS (Diluted) | -9.94 | -19.65 | -23.88 | -27.04 | -32.32 | -30.15 |
| Free Cash Flow | -36.98M | -49.61M | -41.28M | -53.79M | -56.00M | -59.64M |
| Free Cash Flow Per Share | -8.60 | -17.45 | -17.71 | -23.19 | -24.22 | -25.92 |
| EBITDA | -37.37M | -55.43M | -54.34M | -63.95M | -71.78M | -66.59M |
| D&A For EBITDA | 1.45M | 2.19M | 2.87M | 3.68M | 4.12M | 4.18M |
| EBIT | -38.82M | -57.62M | -57.21M | -67.64M | -75.91M | -70.77M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 15.26M | 25.98M | 27.73M | 13.08M | 26.63M | 12.34M |
| Short-Term Investments | 4.83M | 15.84M | 40.89M | 95.22M | 133.28M | 207.25M |
| Cash & Short-Term Investments | 20.09M | 41.82M | 68.62M | 108.30M | 159.91M | 219.59M |
| Other Receivables | 100.00K | 100.00K | 300.00K | 800.00K | 700.00K | |
| Receivables | 100.00K | 100.00K | 300.00K | 800.00K | 700.00K | |
| Prepaid Expenses | 2.07M | 1.83M | 2.89M | 3.63M | 3.37M | 8.23M |
| Total Current Assets | 22.25M | 43.75M | 71.81M | 112.72M | 163.98M | 227.82M |
| Property, Plant & Equipment | 283.00K | 5.89M | 8.72M | 13.43M | 16.91M | 13.99M |
| Other Long-Term Assets | 82.00K | 546.00K | 332.00K | 1.88M | 3.27M | 577.00K |
| Total Assets | 22.62M | 50.18M | 80.86M | 128.04M | 184.16M | 242.39M |
| Accounts Payable | 2.58M | 2.01M | 5.35M | 2.33M | 4.27M | 1.94M |
| Accrued Expenses | 2.77M | 2.42M | 3.30M | 3.78M | 4.23M | 4.45M |
| Current Portion of Leases | 1.06M | 1.00M | 796.00K | 656.00K | 518.00K | |
| Other Current Liabilities | 5.13M | 124.00K | 113.00K | 105.00K | 217.00K | |
| Total Current Liabilities | 6.41M | 10.57M | 9.57M | 6.88M | 9.13M | 6.61M |
| Long-Term Leases | 3.60M | 4.15M | 5.15M | 5.95M | 6.61M | |
| Other Long-Term Liabilities | 455.00K | 526.00K | 661.00K | 785.00K | 899.00K | 2.39M |
| Total Liabilities | 10.47M | 15.24M | 15.39M | 13.62M | 16.63M | 9.00M |
| Common Stock | 4.00K | 4.00K | 2.00K | 28.00K | 28.00K | 28.00K |
| Additional Paid-In Capital | 472.82M | 470.90M | 445.60M | 439.10M | 430.75M | 421.05M |
| Retained Earnings | -460.67M | -435.98M | -380.14M | -324.48M | -261.76M | -187.03M |
| Comprehensive Income & Other | -3.00K | 21.00K | 4.00K | -222.00K | -1.49M | -663.00K |
| Total Common Equity | 12.15M | 34.94M | 65.47M | 114.42M | 167.53M | 233.39M |
| Shareholders' Equity | 12.15M | 34.94M | 65.47M | 114.42M | 167.53M | 233.39M |
| Total Liabilities & Equity | 22.62M | 50.18M | 80.86M | 128.04M | 184.16M | 242.39M |
| Total Debt | 4.67M | 5.15M | 5.95M | 6.61M | 7.12M | |
| Net Cash (Debt) | 15.42M | 36.66M | 62.67M | 101.69M | 152.79M | 219.59M |
| Net Cash Per Share | 3.58 | 12.90 | 26.89 | 43.84 | 66.08 | 95.42 |
| Filing Date Shares Outstanding | 4.58M | 3.56M | 2.33M | 2.33M | 2.31M | 2.31M |
| Total Common Shares Outstanding | 4.07M | 3.51M | 2.33M | 2.33M | 2.31M | 2.31M |
| Working Capital | 15.84M | 33.18M | 62.23M | 105.84M | 154.86M | 221.21M |
| Book Value Per Share | 2.99 | 9.97 | 28.05 | 49.21 | 72.38 | 101.18 |
| Tangible Book Value | 12.15M | 34.94M | 65.47M | 114.42M | 167.53M | 233.39M |
| Tangible Book Value Per Share | 2.99 | 9.97 | 28.05 | 49.21 | 72.38 | 101.18 |
| Machinery | 19.24M | 19.24M | 19.73M | 18.34M | 17.79M | |
| Construction In Progress | 225.00K | 853.00K | 371.00K | |||
| Leasehold Improvements | 9.31M | 9.31M | 9.31M | 9.34M | 8.57M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -42.75M | -55.84M | -55.65M | -62.72M | -74.73M | -69.39M |
| Depreciation & Amortization | 1.45M | 2.19M | 2.87M | 3.68M | 4.12M | 4.18M |
| Loss (Gain) From Sale of Assets | 87.00K | |||||
| Asset Writedown & Restructuring Costs | 5.08M | 1.79M | ||||
| Loss (Gain) From Sale of Investments | -195.00K | -481.00K | -1.23M | -756.00K | 3.05M | 3.02M |
| Stock-Based Compensation | 1.68M | 2.99M | 6.33M | 8.19M | 9.51M | 10.29M |
| Other Operating Activities | 614.00K | 587.00K | 561.00K | 573.00K | 356.00K | |
| Change in Accounts Payable | 34.00K | -3.34M | 3.02M | -1.94M | 2.33M | -1.96M |
| Change in Other Net Operating Assets | -2.90M | 4.30M | 1.51M | 1.40M | -3.42M | |
| Operating Cash Flow | -36.98M | -49.61M | -40.80M | -52.97M | -53.89M | -57.28M |
| Capital Expenditures | -474.00K | -820.00K | -2.12M | -2.36M | ||
| Investment in Securities | 25.79M | 25.56M | 55.78M | 40.09M | 70.09M | 38.96M |
| Investing Cash Flow | 25.79M | 25.56M | 55.31M | 39.27M | 67.98M | 36.60M |
| Long-Term Debt Repaid | -3.47M | |||||
| Net Debt Issued (Repaid) | -3.47M | |||||
| Issuance of Common Stock | 22.79M | 23.54M | 144.00K | 154.00K | 200.00K | 208.00K |
| Other Financing Activities | -1.22M | -1.22M | ||||
| Financing Cash Flow | 21.56M | 22.31M | 144.00K | 154.00K | 200.00K | -3.27M |
| Net Cash Flow | 10.37M | -1.75M | 14.64M | -13.55M | 14.29M | -23.95M |
| Free Cash Flow | -36.98M | -49.61M | -41.28M | -53.79M | -56.00M | -59.64M |
| Free Cash Flow Per Share | -8.60 | -17.45 | -17.71 | -23.19 | -24.22 | -25.92 |
| Levered Free Cash Flow | -23.10M | -28.80M | -23.24M | -33.96M | -29.77M | -37.92M |
| Unlevered Free Cash Flow | -23.10M | -28.80M | -23.24M | -33.96M | -29.77M | -37.87M |
| Cash Interest Paid | 57.00K | 62.00K | 72.00K | 81.00K | 90.00K | 162.00K |
| Change in Working Capital | -2.87M | 954.00K | 4.53M | -1.94M | 3.73M | -5.38M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 28.88M | 49.74M | 21.59M | 31.81M | 39.16M | 165.76M |
| Enterprise Value | 13.46M | 26.02M | -47.59M | -79.64M | -130.05M | -69.58M |
| Last Close Price | 6.31 | 14.19 | 9.25 | 13.68 | 16.92 | 72.00 |
| PB Ratio | 2.11 | 1.42 | 0.33 | 0.28 | 0.23 | 0.71 |
| P/TBV Ratio | 2.38 | 1.42 | 0.33 | 0.28 | 0.23 | 0.71 |
| Debt / Equity Ratio | 0.38 | 0.15 | 0.09 | 0.06 | 0.04 | |
| Net Debt / Equity Ratio | -1.27 | -1.05 | -0.96 | -0.89 | -0.91 | -0.94 |
| Net Debt / EBITDA Ratio | 0.41 | 0.66 | 1.15 | 1.59 | 2.13 | 3.30 |
| Net Debt / FCF Ratio | 0.42 | 0.74 | 1.52 | 1.89 | 2.73 | 3.68 |
| Quick Ratio | 3.15 | 3.97 | 7.20 | 15.85 | 17.60 | 33.23 |
| Current Ratio | 3.47 | 4.14 | 7.50 | 16.38 | 17.97 | 34.48 |
| Return on Equity (ROE) | -204.56% | -111.23% | -61.87% | -44.49% | -37.28% | -26.33% |
| Return on Assets (ROA) | -69.02% | -54.96% | -34.23% | -27.08% | -22.25% | -16.11% |
| Return on Capital Employed (ROCE) | -239.60% | -145.40% | -80.20% | -55.80% | -43.40% | -30.00% |
| Earnings Yield | -157.46% | -112.26% | -257.74% | -197.18% | -190.83% | -41.86% |
| FCF Yield | -128.05% | -99.73% | -191.17% | -169.11% | -143.00% | -35.98% |
| Buyback Yield / Dilution | -83.59% | -21.97% | -0.46% | -0.33% | -0.46% | -0.30% |